... | @@ -5,10 +5,20 @@ |
... | @@ -5,10 +5,20 @@ |
|
* Duran-Frigola et al. *Extending the small molecule similarity principle to all levels of biology*, in preparation
|
|
* Duran-Frigola et al. *Extending the small molecule similarity principle to all levels of biology*, in preparation
|
|
* Duran-Frigola et al. *Formatting biological big data for modern machine learning in drug discovery*, in press
|
|
* Duran-Frigola et al. *Formatting biological big data for modern machine learning in drug discovery*, in press
|
|
|
|
|
|
## Previous related publications from our lab
|
|
## Previous related publications from SB&NB
|
|
|
|
|
|
* Duran-Frigola et al. *A chemo-centric view of human health and disease*, Nature Communications (2014) [[PMID:25435099](https://www.ncbi.nlm.nih.gov/pubmed/25435099)]
|
|
*Sorted by relevance to the CC*
|
|
|
|
|
|
|
|
* Duran-Frigola et al., *A chemo-centric view of human health and disease*, Nature Communications (2014) [[paper](https://www.nature.com/articles/ncomms6676)]
|
|
|
|
* Duran-Frigola et al., *Drug repositioning beyond the low-hanging fruits*, Current Opinion in Systems Biology (2017) [[paper](https://www.sciencedirect.com/science/article/pii/S2452310016300142)]
|
|
|
|
* Duran-Frigola and Aloy, *Analysis of chemical and biological features yields mechanistic insights into drug side effects*, Chemistry and Biology (2013) [[paper](https://www.sciencedirect.com/science/article/pii/S107455211300121X)]
|
|
|
|
* Jaeger, Duran-Frigola et al., *Drug sensitivity in cancer cell lines is not tissue specific*, Molecular cancer (2015) [[paper](https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0312-6)]
|
|
|
|
* Fernández-Torras et al., *Encircling the regions of the pharmacogenomic landscape that determine drug response*, under revision [[paper](https://www.biorxiv.org/content/early/2018/08/02/383588)]
|
|
|
|
* Juan-Blanco et al., *Rationalizing drug response in cancer cell lines*, Journal of Molecular Biology (2018) [[paper](https://www.sciencedirect.com/science/article/pii/S0022283618301700)]
|
|
|
|
* Duran-Frigola, Mosca and Aloy, *Structural systems pharmacology: the role of 3D structures in next-generation drug development*, Chemistry and Biology (2013) [[paper](https://www.sciencedirect.com/science/article/pii/S1074552113000872)]
|
|
|
|
* Duran-Frigola, Siragusa et al., *Detecting similar binding pockets to enable systems polypharmacology*, PLOS Computational Biology (2017) [[paper](http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005522)]
|
|
|
|
* Juan-Blanco et al., *IntSide: a web server for the chemical and biological examination of drug side effects*, Bioinformatics (2014) [[paper](https://academic.oup.com/bioinformatics/article-abstract/31/4/612/2748228)]
|
|
|
|
* Persi, Duran-Frigola, Damaghi, et al., *Systems analysis of intracellular pH vulnerabilities for cancer therapy*, Nature Communications (2018) [[paper](https://www.nature.com/articles/s41467-018-05261-x)]
|
|
|
|
|
|
## Inspirational publications
|
|
## Inspirational publications
|
|
|
|
|
... | | ... | |